The geneTIGA project, led by Professor Petra Reinke and Dr. Dimitrios Laurin Wagner, has been selected for funding under the EU's Horizon Europe framework program.
The project started on 01.07.2022 and will be funded with a total of 5.7 million euros over a period of four years.
The consortium behind the geneTIGA project is taking on the challenge of harnessing the potential of cellular immunotherapies with T cells for diseases other than the treatment of cancer patients, which is currently redefining medicine. The focus is on chronic autoimmune diseases.
Further information on the project can be found here.
All necessary contact details can be found on the subpage "Team".
Back to Overview